MHRA Drug Safety Update November 2020

MHRA Drug Safety Update November 2020

November 18, 2020

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 4 November 2020) has been published and includes articles on:

  • Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy
  • Pirfenidone (Esbriet): risk of serious liver injury, and updated advice on liver function testing
  • Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
  • Bupropion (Zyban): risk of serotonin syndrome with use with other serotonergic drugs
  • Isotretinoin (Roaccutane▼): contribute to expert review
  • Letters and drug alerts sent to healthcare professionals in October 2020 

To see the latest MHRA Drug Safety Updates in full, visit the website

Posted in: ,

More Latest News >

PSNC CEO releases video message

PSNC Chief Executive Simon Dukes has recorded another video message for community pharmacy contractors and their teams. In the video...